Cargando…

Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression

Rectal use of a 1% tenofovir (TFV) gel is currently being evaluated for HIV prevention. While careful assessment of mucosal safety of candidate microbicides is a primary concern, tools to assess mucosal toxicity are limited. Mass spectrometry-based proteomics is a sensitive and high-throughput techn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romas, Laura, Birse, Kenzie, Mayer, Kenneth H., Abou, Max, Westmacott, Garrett, Giguere, Rebecca, Febo, Irma, Cranston, Ross D., Carballo-Diéguez, Alex, McGowan, Ian, Burgener, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2016
Materias:	PReP
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067863/ https://www.ncbi.nlm.nih.gov/pubmed/27316778 http://dx.doi.org/10.1089/aid.2015.0381

Ejemplares similares

Interactive Voice Response System: Data Considerations and Lessons Learned During a Rectal Microbicide Placebo Adherence Trial for Young Men Who Have Sex With Men
por: Bauermeister, Jose, et al.
Publicado: (2017)

Mucosal effects of tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015)

Correction: Mucosal effects for tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015)

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women
por: McGowan, Ian, et al.
Publicado: (2016)

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)
por: Mcgowan, Ian, et al.
Publicado: (2013)

Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates
por: Girard, Lauren, et al.
Publicado: (2018)

Unbiased Proteomics Analysis Demonstrates Significant Variability in Mucosal Immune Factor Expression Depending on the Site and Method of Collection
por: Birse, Kenzie M., et al.
Publicado: (2013)

A Multi-Compartment Single and Multiple Dose Pharmacokinetic Comparison of Rectally Applied Tenofovir 1% Gel and Oral Tenofovir Disoproxil Fumarate
por: Yang, Kuo-Hsiung, et al.
Publicado: (2014)

Mass spectrometry analysis of gut tissue in acute SIV-infection in rhesus macaques identifies early proteome alterations preceding the interferon inflammatory response
por: Berard, A. R., et al.
Publicado: (2023)

Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa
por: Farr Zuend, Christina, et al.
Publicado: (2020)

Pre-exposure prophylaxis use among female sex workers in Gulu city, Uganda: a community-based cross-sectional study
por: Bongomin, Felix, et al.
Publicado: (2023)

Intention to use PrEP among men who have sex with men and engage in chemsex: an international descriptive study
por: de Sousa, Álvaro Francisco Lopes, et al.
Publicado: (2023)

A Comparative Proteomic Analysis of the Soluble Immune Factor Environment of Rectal and Oral Mucosa
por: Romas, Laura M., et al.
Publicado: (2014)

Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract
por: Zevin, Alexander S., et al.
Publicado: (2016)

Acceptability of UC781 Gel as a Rectal Microbicide Among HIV-Uninfected Women and Men
por: Ventuneac, Ana, et al.
Publicado: (2009)

Correction: Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers
por: Birse, Kenzie D. M., et al.
Publicado: (2015)

Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers
por: Birse, Kenzie D. M., et al.
Publicado: (2015)

The effect of tenofovir on renal function in HIV-positive pregnant women
por: Flanagan, Stuart, et al.
Publicado: (2014)

Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices
por: Birse, Kenzie D., et al.
Publicado: (2017)

Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition
por: Noël-Romas, Laura, et al.
Publicado: (2020)

Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel
por: Cranage, Martin, et al.
Publicado: (2008)

An indirect comparison of efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir and dolutegravir + abacavir/lamivudine
por: Rogatto, Felipe, et al.
Publicado: (2014)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

Vaginal deployment and tenofovir delivery by microbicide gels
por: Gao, Y., et al.
Publicado: (2015)

Should the dose of tenofovir be reduced to 200–250 mg/day, when combined with protease inhibitors?
por: Hill, Andrew, et al.
Publicado: (2014)

Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus
por: Farr Zuend, Christina, et al.
Publicado: (2023)

Non-Lactobacillus-Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition
por: Wang, Yiran, et al.
Publicado: (2022)

The Emerging Circadian Phenotype of Borderline Personality Disorder: Mechanisms, Opportunities and Future Directions
por: McGowan, Niall M., et al.
Publicado: (2021)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

The impact of tenofovir disoproxil fumarate on kidney function: four-year data from the HIV-infected outpatient cohort
por: Monteiro, Nadine, et al.
Publicado: (2014)

Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls
por: Farr Zuend, Christina, et al.
Publicado: (2021)

The effect of tenofovir in renal function in HIV-positive adult patients in the Roma health service area, Lesotho, southern Africa
por: Mugomeri, Eltony, et al.
Publicado: (2014)

Failure of daily tenofovir to prevent HIV transmission or the establishment of a significant viral reservoir despite continued antiretroviral therapy
por: Davies, Olubanke, et al.
Publicado: (2014)

Determinants of use of the fixed dose combination emtricitabine/rilpivirine/tenofovir (Eviplera) in HIV-infected persons receiving care in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells
por: Tjomsland, Veronica, et al.
Publicado: (2013)

Correlation between Compartmental Tenofovir Concentrations and an Ex Vivo Rectal Biopsy Model of Tissue Infectibility in the RMP-02/MTN-006 Phase 1 Study
por: Richardson-Harman, Nicola, et al.
Publicado: (2014)

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel
por: Archary, D, et al.
Publicado: (2016)

Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
por: Succop, Stacey M., et al.
Publicado: (2014)

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
por: Carballo-Diéguez, Alex, et al.
Publicado: (2017)

RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells
por: Patel, Hima, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7q3uv6dhs2aevclanibgdstmuo